Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contribution to the maintenance or achievement of a normal body weight (ID 629), brain, eye and nerve development (ID 627, 689, 704, 742, 3148, 3151), maintenance of normal brain function (ID 565, 626, 631, 689, 690, 704, 742, 3148, 3151), maintenance of normal vision (ID 627, 632, 743, 3149) and maintenance of normal spermatozoa motility (ID 628) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
Published:
Adopted:
Meta data
Keywords
Docosahexaenoic acid, DHA, blood lipids, oxidative damage, weight management, brain function, vision, spermatozoa motility, health claims.
On request from
European Commission
Question Number
EFSA-Q-2008-1320
EFSA-Q-2008-1416
EFSA-Q-2008-1417
EFSA-Q-2008-1478
EFSA-Q-2008-3882
EFSA-Q-2008-1352
EFSA-Q-2008-1413
EFSA-Q-2008-1414
EFSA-Q-2008-1415
EFSA-Q-2008-1418
EFSA-Q-2008-1419
EFSA-Q-2008-1476
EFSA-Q-2008-1477
EFSA-Q-2008-1491
EFSA-Q-2008-1529
EFSA-Q-2008-1530
EFSA-Q-2008-3880
EFSA-Q-2008-3881
EFSA-Q-2008-3883
Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen.
Contact
Abstract
No abstract available
© European Food Safety Authority, 2010